OverviewChartNewsTraderScreen

UC DIS.CERT. 12/24 ESL/  DE000HD1NQQ0  /

gettex
21/06/2024  21:46:21 Chg.-0.060 Bid21:59:00 Ask- Underlying Strike price Expiration date Option type
146.280EUR -0.04% 146.110
Bid Size: 200		 -
Ask Size: -		 ESSILORLUXO. INH. EO... - - 31/12/2024 Call
TeleTrader 17/06 Europe markets open higher ahead of BoE decision
TeleTrader 07/05 Europe closes higher after data, earnings
TeleTrader 23/04 Meta adds WhatsApp, Messenger video calling on smart glasses
TeleTrader 19/04 Europe opens lower with Middle East in focus
GlobeNewswire 09/04 DIAGNOS inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
TeleTrader 16/01 Europe opens lower amid economic data
TeleTrader 15/01 Europe closes lower after data
GlobeNewswire 15/11/2023 TuneIn Launches New Integration with HumanWare to Enhance Accessibility for the Visually Impaired Co...
TeleTrader 06/10/2023 Europe opens higher after data
TeleTrader 22/09/2023 Europe opens lower amid data
GlobeNewswire 07/09/2023 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
TeleTrader 31/05/2023 DAX falls 1.5% at close after US job market data
TeleTrader 21/04/2023 Europe closes higher following PMI reports
TeleTrader 21/04/2023 Europe opens mostly lower as earnings, data come in
TeleTrader 08/02/2023 European stocks rise as FTSE 100 hits new record high
TeleTrader 03/02/2023 Europe closes mostly up as business activity recovers
TeleTrader 20/01/2023 Europe closes with modest gains after volatile week
TeleTrader 04/10/2022 Europe closes higher in anticipation of ECB's accounts
TeleTrader 17/06/2022 Europe edges higher as investors await key inflation data
TeleTrader 19/05/2022 Europe opens lower on inflation concerns
TeleTrader 22/04/2022 Europe falls at open amid earnings, data
TeleTrader 14/04/2022 Europe closes higher after ECB, Lagarde's remarks
GlobeNewswire 17/03/2022 SightGlass Vision Joint Venture Begins Operation
TeleTrader 11/03/2022 Europe opens mostly higher, amid inflation, GDP data
GlobeNewswire 10/03/2022 NovaSight Announces Successful Results of Pivotal Amblyopia Treatment Trial